UNSPSC 51281714: Ampicillin anhydrous

This classification denotes a penicillin antibiotic with the molecular formula C16H19N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7C782967RD, chemically known as penicillin, (aminophenylmethyl)- but more generally known as ampicillin, which bears US NIH Compound Identifier 2174.

Ampicillin comes in various forms, including a, acid, anhydrate, anhydrous, base, benzathine, hydrate, natrium, n,n-dibenzylethylenediamine salt, pivaloyloxymethyl ester, pivaloyloxymethyl ester hydrochloride, potassium, sodium, and trihydrate and is often combined with cloxacillin and dicloxacillin sodium. European Medicines Agency schedules Ampicillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05487MIG.

UNSPSC 51281714 Ampicillin anhydrous is a Commodity code that in recent state and local procurement activity covers not ampicillin specifically but a broader range of pharmaceuticals and medical supplies — naloxone and drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter products, and emergency medical consumables such as respiratory equipment, cardiac monitoring electrodes, and airway devices. State and local buyers under this code include county health departments, state health and human services commissions, cities and municipal fire departments, and cooperative purchasing alliances serving multiple jurisdictions. The work ranges from direct procurement of specific pharmaceutical products by single jurisdictions to participation in multistate cooperative purchasing frameworks that establish master agreements with pharmaceutical manufacturers and distributors through authorized wholesalers.

Recent activity spans Florida, Texas, Minnesota (serving multiple states including Oregon), and continues in the Tampa Bay region. Representative recent opportunities include Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the Texas Health and Human Services Commission's Request for Information HHS0017013 (posted April 3, 2026) exploring direct-to-manufacturer prescription programs and therapeutic pharmacy initiatives; the City of Tampa's Invitation to Bid 26-P-00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, with an estimated contract value of $700,000 and a sheltered-market set-aside for certified Small Local Business Enterprises offering a 5 percent bid discount not to exceed $10,000; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., with products effective July 1, 2026.